dr. Emma Orešković

• Specializantka oftalmologije
• emma.oreskovic@svjetlost.hr​

Izobraževanje

Dr. Emma Orešković je diplomirala na Medicinski fakulteti Univerze v Zagrebu leta 2021, kjer je njeno delo bilo usmerjeno na Pluripotente matične celice za regenerativno medicino. Predhodno je končala prakso na Harvard Stem Cell Inštitutu in Univerzi Columbia, kjer se je ukvarjala s preučevanjem najnovejših dosežkov v regenerativni biologiji. Navdušena združevanjem svojih kliničnih in raziskovalnih ambicij, magisterij iz nanotehnologije in regenerativne medicine nadaljuje na Univerzi University College London, kjer se je osredotočila na sintetiziranje personaliziranih biosintetskih roženic, ki vsebujejo nanodelce zlata s ciljem optimiziranja vizualnih napovedi za diabetike in geriatrične paciente.


Dr. Orešković je soavtorica znanstvenih člankov, ki so predstavljeni na več konferencah, vključno The British Society of Nanomedicine in The Royal College of Physicians v Londonu, o temah, ki segajo od načinov uporabe zdravil do novih pristopov k obvladovanju bolečine.
Konference

• 11th March 2023: 10TH EURETINA Winter Meeting, Vilnius, Lithuania.
• August 2022: British Society of Nanomedicine (BSNM) Annual Meeting: Design and fabrication of personalised pro-regenerative cornea: using gold nanoparticles (GNPs) to diminish glycation in a diabetic cornea model, Swansea, UK.
• May 2022: Pain EXPO London: keynote speaker for Medisonal Ltd: The role of novel products for pain management, London, UK.
• March 2022:  Hormone Replacement Therapy Conference, The Royal College of Physicians: novel therapeutic medicines for women’s gynaecologic conditions, London, UK.
• July 2021: 13th annual International Conference on Education and New Learning Technologies; Palma, Spain.

Publikacije

• Journal of Biomedical Sciences: “Tissue Engineering Collagen-Based Implants for Corneal Regeneration” 
• Article for Biomedicines: “Multiorgan pathology and blood pressure disturbances related to Robert’s alcohol-induced gastric lesion and cytoprotection. Stable gastric pentadecapeptide BPC 157.” 
• “Investing Into Health Care Infrastructure” 
• Challenges in the development of questionnaire for assessing quality of distance learning in biomedicine studies